Showing results (751-760 of 919) with videos related to
Sort By:
Pageof 92
Diagnostic Pathology|January 13, 2023
Differential diagnosis of uterine adenosarcoma: identification of JAZF1-BCORL1 rearrangement by comprehensive cancer genomic profilingChie Hasegawa, Kota Washimi, Yukihiko Hiroshima, et al.Annals of Diagnostic Pathology|January 1, 2017
Usefulness of p16/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the diagnosis of biphasic mesotheliomaDi Wu, Kenzo Hiroshima, Toshikazu Yusa, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 3, 2014
Congenital dysfibrinogenemia coincidentally diagnosed at the onset of chronic myelogenous leukemiaTakehiko Kirihara, Yuko Fujikawa, Wataru Takeda, et al.Japanese Journal of Radiology|July 27, 2026
Serial amyloid PET demonstrates marked reduction in amyloid burden following donanemab treatment: a real-world cohort studyYoichi Otomi, Takayoshi Shinya, Hideki Otsuka, et al.Diagnostic Cytopathology|April 16, 2016
Cytologic Differential Diagnosis of Malignant Mesothelioma and Reactive Mesothelial Cells With FISH Analysis of p16Kenzo Hiroshima, Di Wu, Mizue Hasegawa, et al.Journal of Arrhythmia|March 17, 2025
Advancements in BATTERY longevity of cardiac implantable electronic devices from real-world data: BATTERY studyMaiko Kuroda, Michio Nagashima, Masataka Narita, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 9, 2018
[Clinical characteristics of vascular adverse events and significance of peripheral artery disease as a risk factor in chronic myeloid leukemia patients treated with nilotinib]Masahiko Sumi, Keijiro Sato, Nozomu Uematsu, et al.Cancer Gene Therapy|January 7, 2012
Upregulated p53 expression activates apoptotic pathways in wild-type p53-bearing mesothelioma and enhances cytotoxicity of cisplatin and pemetrexedQ Li, K Kawamura, M Yamanaka, et al.Cancers|January 22, 2021
An Analysis of Vertebral Body Growth after Proton Beam Therapy for Pediatric CancerKeiichiro Baba, Masashi Mizumoto, Yoshiko Oshiro, et al.Anticancer Research|December 30, 2023
Asialoglycoprotein Receptor 2 Expression in Patients With Locally Advanced Gastric Cancer After Curative ResectionTakashi Oshima, Itaru Hashimoto, Yukihiko Hiroshima, et al.Pageof 92